Marie Curie stands among the most transformative figures in medical science, a physicist and chemist whose intimate understanding of radioactivity gave birth to an entirely new way of fighting cancer. Long before linear accelerators and precision-targeted beams, Curie’s methodical isolation of radium and polonium provided the raw materials that allowed physicians to attack tumors from within. Her work did not simply add a tool to medicine; it redefined what was possible, turning a mysterious natural phenomenon into a controlled medical technique that has saved millions of lives. This article traces Curie’s journey from her early struggles in partitioned Poland to the radioactive therapy wards of the early 20th century and beyond, examining how her legacy continues to shape modern oncology.

A Determined Path Through Adversity

Maria Skłodowska was born in Warsaw in 1867, when Poland was under Russian control. Her father, a mathematics and physics instructor, nurtured an environment where knowledge was valued, but formal opportunities for women were almost nonexistent. Undeterred, she participated in the clandestine Flying University, an underground educational network that defied Russian restrictions on Polish higher learning. By 1891, she had saved enough to join her sister in Paris, enrolling at the Sorbonne under the French version of her name: Marie.

In Paris, Curie lived in near-poverty, often fainting from hunger while studying late into the night. Her discipline earned her degrees in physics and mathematical sciences, and while searching for laboratory space to explore the magnetic properties of steel, she met Pierre Curie, an established physicist who would become her husband and scientific partner. The union was not only personal but highly productive, combining Pierre’s expertise in electrometers and instrumentation with Marie’s relentless curiosity about the newly discovered rays that Henri Becquerel had stumbled upon in 1896.

Unearthing Radioactive Elements: Polonium and Radium

Marie Curie’s doctoral research focused on the question of why uranium salts emitted rays that could fog photographic plates. She hypothesized that the emission was an atomic property, not a chemical one—an idea that went against prevailing models of the atom. To test this, she began examining minerals containing uranium and thorium, quickly noticing that some samples were far more active than their elemental content could explain. She concluded that the ores must contain tiny amounts of a powerful unknown substance.

Working in a dilapidated shed with minimal ventilation, Marie and Pierre Curie processed tons of pitchblende, a uranium-rich mineral, using laborious chemical procedures to isolate the source. In 1898, they announced the discovery of polonium, named after Marie’s native Poland. Later that same year, they identified an even more intensely radioactive element: radium. It took until 1902 to produce a tenth of a gram of pure radium chloride, a feat that required handling thousands of kilograms of raw ore and set the stage for medical applications.

Understanding the Nature of Radioactivity

While the practical potential of radium was enormous, Curie’s first task was to characterize its properties scientifically. She demonstrated that radioactivity was a fundamental property of certain nuclei, independent of temperature, pressure, or chemical state. This insight challenged the notion of the atom as indivisible and helped lay the groundwork for nuclear physics.

In 1903, the Royal Swedish Academy of Sciences jointly awarded the Nobel Prize in Physics to Henri Becquerel and the Curies for their collective work on radiation. Marie Curie became the first woman to receive a Nobel Prize. The citation recognized the spontaneous radioactivity of Becquerel’s uranium rays and the Curies’ discovery of new radioactive elements, but it was Marie’s systematic measurements and theoretical framing that truly opened the field. A second Nobel Prize followed in 1911, this time in Chemistry, for her isolation of pure radium and determination of its atomic weight—a remarkable recognition that cemented her position as the world’s foremost authority on radioactive materials.

Radium Enters the Medical Domain

Physicians did not wait for a complete understanding of radiation’s mechanism before using it. As early as 1901, doctors experimented with placing radium directly onto skin lesions and tumors, observing that the invisible rays could cause tissues to shrink and sometimes disappear. The observation was empirical: cancerous cells appeared more vulnerable than healthy ones, a differential effect that made radium a promising therapeutic agent.

Marie Curie actively supported the translation of her discoveries into clinical practice. She did not patent her radium-isolation method, believing that pure science belonged to humanity and should not be monopolized for profit. This openness allowed research hospitals around the world to produce small amounts of radium for experimental treatments. By 1904, a radium therapy department had been established at the London Hospital, and similar clinics soon followed in Paris, New York, and Berlin.

Early Brachytherapy and Superficial Treatments

The technique of placing radioactive sources directly inside or near a tumor—known today as brachytherapy—began with simple radium tubes and needles. Physicians would insert these sources into cervical, breast, or skin cancers, delivering a continuous low-dose of radiation over hours or days. For the first time, tumors that could not be fully excised surgically had a non-invasive option that could, in some cases, produce lasting remission.

The treatments were crude by modern standards. Dosimetry was guesswork, and severe burns often occurred because practitioners had no accurate way to measure exposure. The concept of a lethal dose to cancer cells was balanced against the scorching of healthy tissue. Still, patient outcomes improved markedly for certain localized cancers, and the demand for radium soared. Curie’s laboratory became a training ground for hundreds of researchers and clinicians eager to master the safe handling of these powerful materials.

Marie Curie’s Direct Medical Contributions

Curie’s role in medical advancement extended well beyond the laboratory. When World War I broke out in 1914, she recognized that front-line surgeons needed immediate X-ray capabilities to locate bullets and shrapnel. Using her deep knowledge of radiology, she organized a fleet of mobile radiography units—nicknamed “petites Curies”—and trained over 150 women to operate them. She herself drove these vehicles to field hospitals, performing or supervising examinations that guided life-saving surgeries.

This wartime effort involved a parallel medical application: the use of radon gas sealed in tiny glass tubes for sterilizing wounds and treating infected tissues. Radon, a radioactive decay product of radium, could be collected and implanted in small seeds, providing a portable source of radiation for temporary interstitial therapy. Curie oversaw the production of these radon emanation ampoules, extending her impact from diagnostic imaging to therapeutic intervention on the battlefield.

Establishing the Radium Institute

After the war, the University of Paris and the Pasteur Institute worked together to create the Radium Institute, which opened in 1914 but expanded its activities significantly in the 1920s. Divided into two sections—one dedicated to physics and chemistry under Marie Curie’s direction, the other to medical and biological applications under physician Claudius Regaud—the institute became the global center for radiation research. Regaud’s team began to define fractionation protocols, discovering that splitting the total radiation dose into several smaller sessions reduced damage to healthy tissue while still controlling tumors. Curie’s laboratory supplied the radon and radium sources, and she personally mentored a generation of physicists and chemists who would spread these techniques internationally.

The Radium Institute also pioneered what we now call multidisciplinary cancer care. Physicists, biologists, and clinicians worked side by side, sharing data on tissue sensitivity, radioactive decay, and patient responses. This collaborative model, rare at the time, is now standard practice in comprehensive cancer centers. Learn more about the institute’s history and its modern successor at the Institut Curie, which continues to conduct cancer research and treatment.

The Hidden Cost of Discovery

Despite her brilliance, Marie Curie did not fully grasp the biological hazards of long-term radiation exposure. She handled radioactive substances without protective shielding, carried test tubes of radium in her pockets, and worked for decades in rooms with poor ventilation. Her notebooks, now stored in lead-lined boxes at the Bibliothèque Nationale de France, remain so radioactive that they require protective gear to consult—a stark reminder of the invisible danger.

Chronic exposure caused a range of health problems, including persistent fatigue, cataracts, and irreparable damage to her bone marrow. In 1934, Marie Curie died from aplastic anemia, a condition almost certainly triggered by decades of accumulated radiation. Her death highlighted the need for safety standards and dosimetry, prompting the establishment of the International Commission on Radiological Protection, which continues to set exposure limits worldwide. The tragedy reinforced the medical field’s responsibility to balance the therapeutic power of radiation with rigorous protection for both patients and practitioners.

How Radioactive Therapy Works Today

The radioactive therapy pioneered by Curie’s discoveries has evolved into two principal techniques: external beam radiotherapy and internal brachytherapy. In external beam radiotherapy, linear accelerators generate high-energy X-rays or electron beams that are precisely shaped to conform to a tumor’s three-dimensional contours. Image guidance and intensity modulation allow clinicians to deliver sterilizing doses to cancer cells while sparing surrounding organs by millimeter margins.

Brachytherapy, the direct descendant of those early radium implants, now uses sealed sources of iridium-192, cesium-131, or iodine-125. These isotopes are selected for their specific half-lives and energy spectra, matching the treatment to the tumor’s size and location. For prostate cancer, tiny seeds are permanently implanted, releasing radiation over weeks; for cervical cancer, temporary applicators deliver high-dose-rate treatments in a matter of minutes. The National Cancer Institute provides detailed overviews of how these methods are applied today.

Another modern form is targeted radionuclide therapy, where radioactive atoms are attached to molecules that seek out cancer cells. Radium-223 dichloride, for instance, mimics calcium and is absorbed into bone metastases, delivering alpha particles that cause double-strand DNA breaks in tumor cells while minimizing impact on healthy bone marrow. This approach echoes Marie Curie’s vision of using specific radioactive elements to attack disease at its source, now refined through decades of nuclear medicine research.

Marie Curie’s Enduring Influence on Oncology

Curie’s legacy is visible in the routine protocols of radiation oncology departments. The concept of dose fractionation, the use of multiple radiation types, and the biological understanding of how ionizing radiation damages DNA and triggers cell death all trace back to the questions she first asked. Her insistence on open sharing of data and methods has become embedded in the scientific culture, accelerating the pace of clinical breakthroughs.

Her influence also catalyzed the creation of other research centers. The Marie Curie Charity in the United Kingdom, for example, provides hospice and supportive care for terminally ill patients, often integrating palliative radiotherapy. Similarly, the Nobel Foundation’s biography highlights how her dual prizes inspired public and political support for science, particularly for women in research. Today, the European Commission’s Marie Skłodowska-Curie Actions fund researchers across disciplines, ensuring that her name remains synonymous with scientific excellence and international collaboration.

One of the most remarkable illustrations of Curie’s impact is the persistence of the Curie medical tradition. The Institut Curie in Paris treats thousands of cancer patients annually and operates a research center where physicists and biologists investigate new radiosensitizers and particle therapy techniques. The institute’s hospital was among the first to use proton therapy, a highly focused form of radiation that relies on principles first glimpsed in Curie’s era. For a closer look at current radium-based treatments, see the International Atomic Energy Agency’s primer on radiotherapy, which underscores how low-income countries are now gaining access to this life-saving modality.

Lessons from a Life of Rigor and Generosity

Marie Curie’s story offers more than a historical account. It demonstrates that profound medical advances often arise from fundamental scientific curiosity rather than direct clinical inquiry. The discovery of radium was not motivated by a search for cancer cures; it emerged from a deep desire to understand why matter emitted energy. Yet that knowledge transformed oncology within a single generation.

Moreover, Curie’s ethical choices—refusing to patent radium, prioritizing humanitarian applications during war, and training women scientists at a time when they were barred from most laboratories—set a standard for how research can serve society. The radioactive therapy she enabled would later be refined by others, but the principle remained consistent: harness the energy of the atom to destroy malignant cells while preserving health. Today’s radiation oncologists, medical physicists, and dosimetrists are the direct intellectual heirs of the woman who once stood in a leaking shed, stirring cauldrons of pitchblende, driven by the conviction that nature concealed secrets worth a lifetime of effort.

Conclusion

Marie Curie did not design a linear accelerator or outline a treatment planning algorithm. What she did was more fundamental: she discovered the elements and the atomic properties that made radioactive therapy possible. Her work illuminated the path from uranium rays to modern brachytherapy, from crude radium plasters to precision-targeted radionuclides. By allying rigorous physics with medical ambition, she helped forge a discipline that now cures cancers that were once uniformly fatal. Every time a patient receives radiation and walks away free of disease, the invisible thread leads back to Curie’s notebooks, her unwavering dedication, and her belief that science, placed in the hands of healers, can change the world.